6β-Acetoxynortropane:  A Potent Muscarinic Agonist with Apparent Selectivity toward M2-Receptors

Journal of Medicinal Chemistry
1998.0

Abstract

A series of tropane derivatives, related in structure to baogongteng A (1), an alkaloid from a Chinese herb, were synthesized. 6beta-Acetoxynortropane (5) had weak affinity (Ki 22 microM) for central (M1) muscarinic receptors in a [3H]quinuclidinyl benzilate binding assay but had extremely high affinity (Ki 2.6 nM) and selectivity for M2-muscarinic receptors expressed in CHO cells. It had 13-fold lower affinity for M4-receptors, 260-fold lower affinity for M3-receptors, and 8200-fold lower affinity for M1-receptors expressed in CHO cells. The 6beta-carbomethoxy analogue (14) of baogongteng A had only weak affinity for M2-muscarinic receptors, as did 6beta-carbomethoxynortropane (13) and 6beta-acetoxytropane (4). In transfected CHO cells, 6beta-acetoxynortropane (5) was an agonist at M2-receptors, based on a GTP-elicited decrease in affinity, and a full agonist with an IC50 of 11 nM at M4-receptors, based on inhibition of cyclic AMP accumulation, while being a full agonist at M1-receptors with an EC50 of 23 nM and a partial agonist at M3-receptors with an EC50 of 3.6 nM, based in both cases on stimulation of phosphoinositide breakdown. All of the 16 tropane derivatives had weak affinities for central alpha4beta2-nicotinic receptors with 6beta-carbomethoxynortropane (13) having the highest affinity, which was still 150-fold less than that of nicotine. 6beta-Acetoxynortropane (5) represents a potent muscarinic agonist with apparent selectivity toward M2-receptors.

Knowledge Graph

Similar Paper

6β-Acetoxynortropane:  A Potent Muscarinic Agonist with Apparent Selectivity toward M<sub>2</sub>-Receptors
Journal of Medicinal Chemistry 1998.0
6β-Acyloxy(nor)tropanes:  Affinities for Antagonist/Agonist Binding Sites on Transfected and Native Muscarinic Receptors
Journal of Medicinal Chemistry 2000.0
Activity and QSAR study of baogongteng A and its derivatives as muscarinic agonists
Bioorganic &amp; Medicinal Chemistry Letters 2005.0
Synthesis and biological investigation of potential atypical antipsychotics with a tropane core. Part 1
European Journal of Medicinal Chemistry 2011.0
Synthesis and in vitro characterization of novel amino terminally modified oxotremorine derivatives for brain muscarinic receptors
Journal of Medicinal Chemistry 1992.0
Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships
Journal of Medicinal Chemistry 1991.0
Synthesis and muscarinic receptor activity of ester derivatives of 2-substituted 2-azabicyclo[2.2.1]heptan-5-ol and -6-ol
Journal of Medicinal Chemistry 1992.0
Bioisosteres of Arecoline: 1,2,3,6-Tetrahydro-5-pyridyl-Substituted and 3-Piperidyl-Substituted Derivatives of Tetrazoles and 1,2,3-Triazoles. Synthesis and Muscarinic Activity
Journal of Medicinal Chemistry 1994.0
Synthesis and binding affinity of new muscarinic ligands structurally related to oxotremorine
Bioorganic &amp; Medicinal Chemistry Letters 1997.0
Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines
Journal of Medicinal Chemistry 1992.0